Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells

Journal of Clinical Investigation

Volumn 110, Issue 11, 2002, Pages 1619-1628

  Uemura, Akiyoshi ^a   Ogawa, Minetaro ^a   Hirashima, Masanori ^a   Fujiwara, Takashi ^b   Koyama, Shinji ^a   Takagi, Hitoshi ^a   Honda, Yoshihito ^a   Wiegand, Stanley J ^c   Yancopoulos, George D ^c   Nishikawa, Shin Ichi ^a,d  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; MONOCLONAL ANTIBODY; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL TYPE; CONTROLLED STUDY; DIABETIC RETINOPATHY; MOLE RAT; MOUSE; MURAL CELL; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA EDEMA; RETINA HEMORRHAGE; STRUCTURE ANALYSIS;

EID: 0036896814     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215621     Document Type: Article

References (56)

1. Risau, W. 1997. Mechanisms of angiogenesis. Nature. 386:671-674.
2. Yancopoulos, G.D., et al. 2000. Vascular-specific growth Factors and blood vessel formation. Nature. 407:242-248.
3. Beck, L., Jr., and D'Amore, P.A. 1997. Vascular development: Cellular and molecular regulation. FASEB J. 11:365-373.
4. Carmeliet, P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389-395.
5. Gale, N.W., and Yancopoulos, G.D. 1999. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13:1055-1066.
6. Jones, N., Iljin, K., Dumont, D.J., and Alitalo, K. 2001. Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2:257-267.
7. Lindahl, P., Hellstrom, M., Kalen, M., and Betsholtz, C. 1998. Endothelial-perivascular cell signaling in vascular development: Lessons from knockout mice. Curr. Opin. Lipidol. 9:407-411.
8. Betsholtz, C., Karlsson, L., and Lindahl, P. 2001. Developmental roles of platelet-derived growth factors. Bioessays. 23:494-507.
9. Dumont, D.J., Yamaguchi, T.P., Conlon, R.A., Rossant, J., and Breitman, M.L. 1992. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene. 7:1471-1480.
10. Dumont, D.J., Gradwohl, G.J., Fong, G.H., Auerbach, P., and Breitman, M.L. 1993. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene. 8:1293-1301.
11. Sato, T.N., Qin, Y., Kozak, C.A., and Audus, K.L. 1993. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA. 90:9355-9358.
12. Davis, S., et al. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1161-1169.
13. Holmgren, L., Glaser, A., Pfeifer-Ohlsson, S., and Ohisson, R. 1991. Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development. 113:749-754.
14. Lindahl, P., Johansson, B.R., Leveen, P., and Betsholtz, C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 277:242-245.
15. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., and Betsholtz, C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 126:3047-3055.
16. Dumont, D.J., et al. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1897-1909.
17. Sato, T.N., et al. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:70-74.
18. Suri, C., et al. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180.
19. Patan, S. 1998. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc. Res. 56:1-21.
20. Leveen, P., et al. 1994. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1875-1887.
21. Soriano, P. 1994. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8:1888-1896.
22. Hellstrom, M., et al. 2001. Lack of pericytes leads to endothelial hyerplasia and abnormal vascular morphogenesis. J. Cell Biol. 153:543-554.
23. Folkman, J., and D'Amore, P.A. 1996. Blood vessel formation: What is its molecular basis? Cell. 87:1153-1155.
24. Puri, M.C., Partanen, J., Rossant, J., and Bernstein, A. 1999. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development. 126:4569-4580.
25. Jones, N., et al. 2001. Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep. 2:438-445.
26. Stone, J., and Maslim, J. 1997. Mechanisms of Retinal Angiogenesis. Progress in Retinal and Eye Research. 16:157-181.
27. Sano, H., et al. 2001. Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation. 103:2955-2960.
28. Yano, M., et al. 1997. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood. 89:4317-4326.
29. Takakura, N., et al. 1998. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity. 9:677-686.
30. Maisonpierre, P.C., et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:55-60.
31. Adachi, S., Yoshida, H., Kataoka, H., and Nishikawa, S. 1997. Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol. 9:507-514.
32. Fujiwara, T., and Uehara, Y. 1992. The cytoarchitecture of the medial layer in rat thoracic aorta: A scanning electron-microscopic study. Cell Tissue Res. 270:165-172.
33. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
34. Benjamin, L.E., Hemo, I., and Keshet, E. 1998. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 125:1591-1598.
35. Nehls, V., and Drenckhahn, D. 1991. Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J. Cell Biol. 113:147-154.
36. Fruttiger, M., et al. 1996. PDGF mediates a neuron-astrocyte interaction in the developing retina. Neuron. 17:1117-1131.
37. Orlidge, A., and D'Amore, P.A. 1987. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105:1455-1462.
38. Hirschi, K.K., Rohovsky, S.A., Beck, L.H., Smith, S.R., and D'Amore, P.A. 1999. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84:298-305.
39. Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103:159-165.
40. Kuwabara, T., and Cogan, D.G. 1963. Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch. Ophthalmol. 69:492-502.
41. Vracko, R., and Benditt, E.P. 1970. Capillary basal lamina thickening. Its relationship to endothelial cell death and replacement. J. Cell Biol. 47:281-285.
42. Crosby, J.R., Seifert, R.A., Soriano, P., and Bowen-Pope, D.F. 1998. Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages. Nat. Genet. 18:385-388.
43. Sano, H., et al. 2002. Blockade of platelet-derived growth factor receptor-β pathway induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am. J. Pathol. 161:135-143.
44. Stalmans, I., et al. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109:327-336. doi:10.1172/JC1200214362.
45. Fruttiger, M. 2002. Development of the mouse retinal vasculature: Angiogenesis versus vasculogenesis. Invest. Ophthalmol. Vis. Sci. 43:522-527.
46. Hirschi, K.K., and D'Amore, P.A. 1996. Pericytes in the microvasculature. Cardiovasc. Res. 32:687-698.
47. Darland, D.C., and D'Amore, P.A. 1999. Blood vessel maturation: Vascular development comes of age. J. Clin. Invest. 103:157-158.
48. Hackett, S.F., et al. 2000. Angiopoietin 2 expression in the retina: Upregulation during physiologic and pathologic neovascularization. J. Cell. Physiol. 184:275-284.
49. Thurston, G., et al. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 286:2511-2514.
50. Thurston, G., et al. 2000. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6:460-463.
51. Hanahan, D. 1997. Signaling vascular morphogenesis and maintenance. Science. 277:48-50.
52. Xu, Y., and Yu, Q. 2001. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J. Biol. Chem. 276:34990-34998.
53. Procopio, W.N., Pelavin, P.I., Lee, W.M.F., and Yeilding, N.M. 1999. Angiopoietin-1 and -2 coiled coil domains mediate distinct homooligomerization patterns, but fibrinogen-like domains mediate ligand activity. J. Biol. Chem. 274:30196-30201.
54. Carlson, T.M., Feng, Y., Maisonpierre, P.C., Mrksich, M., and Morla, A.O. 2001. Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276:26516-26525.
55. Suri, C., et al. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science. 282:468-471.
56. Joussen, A.M., et al. 2002. Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 160:1683-1693.